Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
National Journal of Andrology ; (12): 410-412, 2006.
Article in Chinese | WPRIM | ID: wpr-343610

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the predictive value of serum inhibin B (INH B) levels as an indicator of the presence of testicular spermatozoa in nonobstructive azoospermia.</p><p><b>METHODS</b>Forty patients with nonobstructive azoospermia (NOA), 20 patients with obstructive azoospermia (OA), and 10 fertile volunteers were involved in this study. A chemoluminescence method was used to measure the levels of FSH; Inhibin B was analysed by using sandwich enzyme-linked immuno-sorbent assay.</p><p><b>RESULTS</b>Patients with nonobstructive azoospermia has significantly higher levels of serum FSH [(21.34 +/- 12.15) IU/L] and significantly lower levels of inhibin B [(53.15 +/- 58.74) ng/L] than patients with obstructive azoospermia [FSH: (3.94 +/- 1.52) IU/L, INH B: (162.49 +/- 78.38) ng/L, P < 0.01] and fertile volunteers [FSH: (4.27 +/- 2.84) IU/L, INH B: (228.49 +/- 110.68) ng/L, P < 0.01]. Mean serum inhibin B were significantly higher in patients with nonobstructive azoospermia who had spermatozoa on TESE than in those in whom no spermatozoa was found on TESE [INHB: (90.31 +/- 72.18) ng/L vs (19.54 +/- 20.38) ng/L, r = 0.528, P < 0.01], but mean FSH levels did not have similar predictive power (P > 0.05).</p><p><b>CONCLUSION</b>Serum INH B level seems to be more accurate than serum FSH in the prediction of presence of testicular spermatozoa in patients with nonobstructive azoospermia. Serum inhibin B determination may be substitute of TESE as a diagnostic index.</p>


Subject(s)
Adult , Humans , Male , Azoospermia , Blood , Diagnosis , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Follicle Stimulating Hormone , Blood , Inhibins , Blood , Luminescent Measurements , Predictive Value of Tests , Spermatozoa , Physiology , Testis , Physiology , General Surgery
2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 794-796, 2005.
Article in Chinese | WPRIM | ID: wpr-269897

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical efficacy of integrative traditional Chinese and Western medicine on polycystic ovarian syndrome (PCOC).</p><p><b>METHODS</b>Sixty-three patients with polycystic ovarian syndrome were randomly allocated into 2 groups, 31 patients orally administered with diane-35 in the Western medicine group (WMG) and 32 patients treated with conventional controlled medicine plus modified Yougui Pill in the integrative medicine group (IMG). Changes of relevant hormones and clinical syndromes in patients were detected before treatment, after 3 cyclic treatment and at the 6th cycle after treatment.</p><p><b>RESULTS</b>The levels of relevant hormones and the indexes of B-ultrasonic were obviously improved after treatment in the two groups. But 6 cycles after treatment, these changes restored to the baseline as those before treatment in WMG, while maintained in IMG (P < 0.01). What's more, the normalization of menstruation, ovulation and pregnancy rate in IMG were significantly higher than those in WMG (P < 0.01).</p><p><b>CONCLUSION</b>Diane-35 combined with modified yougui pill in treating polycystic ovarian syndrome not only shows marked short-term effect, but could consolidate the curative effect.</p>


Subject(s)
Adult , Female , Humans , Androgen Antagonists , Therapeutic Uses , Cyproterone Acetate , Therapeutic Uses , Drug Administration Schedule , Drug Combinations , Drug Therapy, Combination , Drugs, Chinese Herbal , Therapeutic Uses , Ethinyl Estradiol , Therapeutic Uses , Phytotherapy , Polycystic Ovary Syndrome , Drug Therapy , Tablets
SELECTION OF CITATIONS
SEARCH DETAIL